Imprint  |  Sitemap  |  Search

 
News
19.07.2010
AiCuris presents mechanism of action investigations of its novel anti-HCMV drug AIC246 at the International Herpesvirus Workshop

Job Opportunities
Volljuristen (m/w)

Postdoc (m/w) für die antivirale Forschung

Medical Expert (m/f)

Project Leader (m/f)

Medical Writer (m/f)

Quality Assurance Manager / GxP-Auditor (m/f)

Controller (m/f)

Senior Statistician/Biometrician (m/f)

Dr. Holger Zimmermann (CSO)

Position:

Chief Scientific Officer (CSO) 

Academic degree:

PhD in Biology

Academic experience:

7 years in academic institutes, including 3 years at the Institute of Molecular and Cell Biology (IMCB), National University of Singapore

Industrial experience:

2000-2006 at Bayer (lastly as Director of Antiviral Research)
2006-2008 Head of Virology at AiCuris

Memberships:

  • Member of the International Society of Antiviral Research (ISAR) and Committee Member of the ISAR Membership Committee
  • Member of the German Society of Virology (GfV) and Committee member of the GfV Antiviral Therapy Committee
  • Editorial Board Member of the journal "Antiviral Chemistry & Chemotherapy" 

Publications:

Author/Co-author of 20 scientific publications (peer-reviewed articles, reviews, bookchapters)

Patents:

named author of 24 patents

Dr. Holger Zimmermann

AiCuris GmbH & Co. KG
Friedrich-Ebert-Str. 475
42117 Wuppertal

Phone:
+49 (0)202 317 63 - 0
Fax:
+49 (0)202 317 63 - 1177

E-Mail:
info(at)aicuris.com